Shilpa Medicare Ltd

SHILPAMED

Company Profile

  • Business description

    Shilpa Medicare Ltd is a specialty and generic drug manufacturer. The company deals in high-quality Active Pharmaceutical Ingredients (APIs), Intermediates, Formulations, New Drug Delivery Systems, Peptides, Biotech products, and Specialty Chemicals etc. Its portfolio comprises various oncology and non-oncology-related APIs such as anastrozole, acebrophylline, busulphan, decitabine, etc, and finished dosage formulations such as apremilast tablets, clofarabine injection, docetaxel injection, etc., in various therapy areas. Its reporting segments are: Pharmaceutical product and services, which derive maximum revenue, Power sales, and Others. Geographically, the company generates maximum revenue from India, followed by Europe, the United States of America, and the Rest of the world.

  • Contact

    Hyderabad Road
    No. 12-6-214/A-1, Shilpa House
    RaichurKA584135
    IND

    T: +91 8532238704

    https://www.vbshilpa.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 March 2026

    Employees

    998

Stocks News & Analysis

stocks

Bluescope offer knocked back by board

Our view on the potential for additional offers.
stocks

AI stocks winners, laggards and losers for 2025

AI stocks flew high in 2025 despite year-end volatility. Palantir and Lam look overvalued, but opportunities remain.
stocks

12 picks for an income portfolio - Q4 2025 update

Eighteen months in and passive income growth has exceeded my target.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,092.7025.500.28%
CAC 408,339.6022.49-0.27%
DAX 4025,317.7456.100.22%
Dow JONES (US)49,504.07237.960.48%
FTSE 10010,118.945.66-0.06%
HKSE26,608.48376.691.44%
NASDAQ23,671.35191.330.81%
Nikkei 22551,939.89822.631.61%
NZX 50 Index13,683.2912.96-0.09%
S&P 5006,966.2844.820.65%
S&P/ASX 2008,759.4025.800.30%
SSE Composite Index4,165.2944.861.09%

Market Movers